Clinical Trial Update: Palonosetron Associated to Aprepitant in Prophylaxis of PONV [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the combination of palonosetron and aprepitant for prophylaxis of postoperative nausea and vomiting; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)
• Palonosetron (palonosetron)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: UNKNOWN